High urgency

US-CONGRESS BILLS-119hr8481eh: Kayleigh’s Law Act of 2026

Detected September 2, 2026 · in Pharmacy & Controlled Substances

Kayleigh’s Law Act of 2026 introduces new regulations for pharmacies regarding prescription drug monitoring and controlled substances management.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.

What changed

New requirements for prescription drug monitoring programs (PDMP) and enhanced oversight on controlled substances dispensing and compounding.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies.

What you must do

Review and update compliance protocols for PDMP and controlled substances management.

Deadline

Not specified.

Source: https://www.govinfo.gov/app/details/BILLS-119hr8481eh

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances